home / stock / grfs / grfs news


GRFS News and Press, Grifols S.A. From 12/29/23

Stock Information

Company Name: Grifols S.A.
Stock Symbol: GRFS
Market: NASDAQ
Website: grifols.com

Menu

GRFS GRFS Quote GRFS Short GRFS News GRFS Articles GRFS Message Board
Get GRFS Alerts

News, Short Squeeze, Breakout and More Instantly...

GRFS - Grifols gains on plans to sell 20% of Shanghai RAAS stake to Haier

2023-12-29 12:01:35 ET More on Grifols Grifols Is Building Momentum Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols said to be in talks for a partial sale of Shanghai RAAS Seeking Alpha’s Quant Rating on Grifols S.A. Historical ea...

GRFS - Palatin Technologies, Cellectis among healthcare movers

2023-12-29 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Healthcare and utilities could perform better in 2024 - analyst Arcus, Bristol-Myers, ...

GRFS - Doubling Down On Gain Therapeutics

2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...

GRFS - Grifols S.a. ($GRFS) Proactive Strategies

2023-12-11 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

GRFS - Grifols Is Building Momentum

2023-12-08 17:34:26 ET Summary Argenx's failure removes competitive pressure on Grifols' immunoglobulin franchise. Grifols is in advanced negotiations to sell Shanghai RAAS, which would eliminate short-term debt concerns. Grifols' Q3 results showed increased sales, improved EB...

GRFS - Grifols said to be in talks for a partial sale of Shanghai RAAS

2023-11-29 08:21:29 ET More on Grifols Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols: Cheap For A Reason Historical earnings data for Grifols, S.A. Financial information for Grifols, S.A. Historical earnings data for Grifols, S.A. ...

GRFS - Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript

2023-11-02 22:33:06 ET Grifols, S.A. (GRFS) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Nuria Pascual - IR and Sustainability Officer Thomas Glanzmann - Executive Chairman and CEO Victor Grifols Deu - COO Alfredo Arroyo -...

GRFS - Grifols S.A. Q3 2023 Earnings Preview

2023-11-01 12:31:13 ET More on Grifols S.A. Grifols: Cheap For A Reason Seeking Alpha’s Quant Rating on Grifols S.A. Historical earnings data for Grifols S.A. Financial information for Grifols S.A. For further details see: Grifols S.A. Q3 2...

GRFS - Grifols' unit gets expansion of its contract with the U.S. Department of Defense

2023-10-19 08:24:17 ET More on Grifols S.A. Grifols: Cheap For A Reason Grifols, S.A. (GRFS) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Grifols S.A. For further details see: Grifols' unit gets expansion of its contract with th...

GRFS - Grifols: Cheap For A Reason

2023-09-21 13:56:01 ET Summary Grifols is a Spanish pharmaceutical company focused on blood plasma products, with a strong market position and an attractive growth pathway. The shares have underperformed peers and yielded negative returns over the last five years. We believe t...

Previous 10 Next 10